网络元分析:在性结肠炎中使用先进疗法进行组织学和组织内镜改善和缓解
Maria Manuela Estevinho1,2, Bernardo Sousa-Pinto3, Paula Leão Moreira4
1Department of Gastroenterology, Unidade Local de Saúde Gaia Espinho, Vila Nova de Gaia, Portugal.
小分子在达到性结肠炎 (UC) 患者的组织学终点方面表现出有效性. 这项网络元分析比较了先进疗法,强调了etrasimod和upadacitinib的严格结果.
科学领域:
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 组织学是性结肠炎 (UC) 的预后指标.
- 对UC疗法的组织学终点的直接比较数据有限.
研究的目的:
- 进行网络元分析 (NMA),比较中度至重度UC的生物药物和小分子组织学结果.
- 根据组织学改善和缓解,评估先进疗法的相对疗效.
主要方法:
- 在2024年7月之前,对四个随机对照试验 (RCT) 数据库进行系统搜索.
- 包括RCT报告UC的组织学终点 (改善,缓解,组织内镜改善).
- 应用随机效应频率模型来计算药物疗效的相对风险和P-score.
主要成果:
- 分析了24个RCT,涉及15种疗法和8874名患者.
- 在诱导期间,Etrasimod 2 mg/天在组织学改善和缓解方面显示出最高的疗效.
- 在维护期间,Upadacitinib 30 mg/天显示出优异的组织学和组织内镜改善.
结论:
- 小分子在中度至重度UC中有效地达到严格的组织学终点.
- 对于生物药物的组织学数据有限,特别是在维持治疗期间.
- 头对头随机对照试验对于最终的临床指导至关重要.
更多相关视频
09:42Murine Endoscopy for In Vivo Multimodal Imaging of Carcinogenesis and Assessment of Intestinal Wound Healing and Inflammation
Published on: August 26, 2014
09:01Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
